Rate control in the medical management of atrial fibrillation

Heart

Volumn 93, Issue 1, 2007, Pages 35-38

  Camm, A J ^a   Savelieva, I ^a   Lip, G Y H ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM ANTAGONIST; DIGOXIN; ESMOLOL;

CARDIOVASCULAR RISK; CARDIOVERSION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HOSPITALIZATION; HUMAN; MEDICAL RESEARCH; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SINUS RHYTHM; STROKE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; PATIENT SELECTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33846235803     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.099903     Document Type: Conference Paper

References (36)

1. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 2003;114:51-5.
2. Freestone B, Lip GYH. Heart rate control. In: Lip GYH, Godtfredsen J, eds. Cardiac arrhythmias: a clinical approach. Edinburgh: Mosby, 2003:275-98.
3. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology, J Am Coll Cardiol 2001;38:1231-66.
4. Boyd KM, Clark DH, Colthart AB, et al. Final consensus statement of the Royal College of Physicians of Edinburgh Consensus Conference on atrial fibrillation in hospital and general practice, 3-4 September 1998. Br J Haematol 1999;104:195-6.
5. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-6.
6. Rawles JM. What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 1990;63:157-61.
7. Beasley R, Smith DA, McHaffie DJ. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. BMJ (Clin Res Ed) 1985;290:9-11.
8. Farshi R, Kistner D, Sarma JS, et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol 1999;33:304-10.
9. Li-Saw-Hee FL, Lip GYH. Digoxin revisted. QJM 1998;91:259-64.
10. Khand AU, Rankin AC, Martin W, et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 2003;42:1944-51.
11. Segal JB, McNamara RL, Miller MR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000;49:47-59.
12. Olshansky B, Rosenfeld LE, Warner AL, et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004;43:1201-8.
13. Wong CK, Lau CP, Leung WH, et al. Usefulness of labetalol in chronic atrial fibrillation. Am J Cardiol 1990;66:1212-5.
14. Roth A, Harrison E, Mitani G, et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart-rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 1986;73:316-24.
15. Lewis RV, Laing E, Moreland TA, et al. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation. Eur Heart J 1988;9:279-83.
16. Cooper HA, Bloomfield DA, Bush DE, et al. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study). Am J Cardiol 2004;93:1247-53.
17. Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000;101:1138-44.
18. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
19. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
20. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate control versus rhythm control in persistent atrial fibrillation: the Strategies of Treatment in Atrial Fibrillation (STAF) Study. J Am Coll Cardiol 2003;41:1690-6.
21. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94.
22. Opolski G, Torbicki A, Kosior DA, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-86.
23. Vora A, Karnad D, Goyal V, et al. Control of heart rate versus rhythm in rheumatic atrial fibrillation: a randomized study. J Cardiovasc Pharmacol Ther 2004;9:65-73.
24. Gronefeld GC, Lilienthal J, Kuck KH, et al. Pharmacological-Intervention-in-Atrial-Fibrillation. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results From a prospective randomized study. Eur Heart J 2003;24:1430-6.
25. Carlsson J, Micus S, Haun S, et al. Rate control and rhythm control improve quality of life in patients with atrial fibrillation: results from STAF (Strategies of Treatment of Atrial Fibrillation) [abstract] Circulation 2001;104:II-774.
26. Hagens VE, Ranchor AV, Van Sonderen E, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004;43:241-7.
27. Jenkins LS, Brodsky M, Schron E, et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:112-20.
28. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13.
29. Steinberg JS, Sadaniantz A, Kron J, et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004;109:1973-80.
30. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
31. Swedberg K, Olsson LG, Charlesworth A, et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 2005;26:1303-8.
32. Al-Khatib SM, Shaw LK, Lee KL, et al. Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure? Am J Cardiol 2004;94:797-800.
33. Hagens VE, Crijns HJ, Van Veldhuisen DJ, et al. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J 2005;149:1106- 11.
34. AF-CHF Investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002;144:597-607.
35. Hagens VE, Vermeulen KM, TenVergert EM, et al. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation-results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J 2004;25:1542-9.
36. Marshall DA, Levy AR, Vidaillet H, et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004;141:653-61.